{"id":967283,"date":"2026-05-27T07:14:50","date_gmt":"2026-05-27T11:14:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/"},"modified":"2026-05-27T07:14:50","modified_gmt":"2026-05-27T11:14:50","slug":"teva-pharmaceuticals-commits-to-veeva-vault-crm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/","title":{"rendered":"Teva Pharmaceuticals Commits to Veeva Vault CRM"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p class=\"prntac\">\n        <i>Agentic CRM with industry-specific AI for deeper customer engagement<\/i>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\">PLEASANTON, Calif.<\/span>, <span class=\"legendSpanClass\">May 27, 2026<\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/www.veeva.com\/\" target=\"_blank\" rel=\"nofollow\">Veeva Systems<\/a> (NYSE: VEEV) today announced that Teva Pharmaceuticals has committed to <a href=\"https:\/\/www.veeva.com\/products\/crm-suite\/crm\/\" target=\"_blank\" rel=\"nofollow\">Veeva Vault CRM<\/a> globally.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2988323\/Teva_Pharmaceuticals_Commits_to_Veeva.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2988323\/Teva_Pharmaceuticals_Commits_to_Veeva.jpg\" title=\"Teva Pharmaceuticals Commits to Veeva Vault CRM\" alt=\"Teva Pharmaceuticals Commits to Veeva Vault CRM\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>&#8220;We are excited to expand our strategic partnership with Veeva by moving to Vault CRM,&#8221; said Lavanya Narasimhamurthy, global vice president of IT at Teva. &#8220;We share a deep commitment to customer success, and Vault CRM will provide Teva the technical foundation to drive commercial execution.&#8221;<\/p>\n<p>&#8220;From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars, and pharmacy brands worldwide, Teva is dedicated to addressing patients&#8217; needs,&#8221; said Veeva President and CCO Tom Schwenger. &#8220;We are honored to extend our strategic partnership with Teva to include Veeva Vault CRM.&#8221;<\/p>\n<p>Vault CRM is part of the Vault CRM Suite of applications that provide the technology foundation for commercial execution. Vault CRM includes the <a href=\"https:\/\/www.veeva.com\/products\/commercial-cloud\/?wvideo=lofkbfftdk\" target=\"_blank\" rel=\"nofollow\">Agentic Call Report<\/a> to generate Commercial Evidence, using compliant free text to drive insights to increase commercial agility.<\/p>\n<p>\n        <b>About Veeva Systems<br \/><\/b>Veeva delivers the industry cloud for life sciences with software, AI, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world&#8217;s largest pharmaceutical companies to emerging biotechs. As a <a href=\"https:\/\/www.veeva.com\/pbc\/\" target=\"_blank\" rel=\"nofollow\">Public Benefit Corporation<\/a>, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit <a href=\"http:\/\/veeva.com\/\" target=\"_blank\" rel=\"nofollow\">veeva.com<\/a>.<\/p>\n<p>\n        <b>Veeva Forward-Looking Statements<br \/><\/b>This release contains forward-looking statements regarding Veeva&#8217;s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended January 31, 2026, which you can find <a href=\"https:\/\/www.sec.gov\/ix?doc=\/Archives\/edgar\/data\/0001393052\/000139305226000014\/veev-20260131.htm\" target=\"_blank\" rel=\"nofollow\">here<\/a> (a summary of risks which may impact our business can be found on pages 13 and 14), and in our subsequent SEC filings, which you can access at <a href=\"https:\/\/www.sec.gov\/\" target=\"_blank\" rel=\"nofollow\">sec.gov<\/a>.<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <b><br \/>\n                    <span class=\"prnews_span\">Contact:<\/span><br \/>\n                  <\/b><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prnpr2 prnpl2 prnvat prnsbtb1 prnrbrb1 prnsbbb1 prnsblb1\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Maria Scurry<br \/>Veeva Systems<br \/><a href=\"mailto:maria.scurry@veeva.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">maria.scurry@veeva.com<\/a>\u00a0<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Meera Lakhani-Patel<br \/>Veeva Systems, Europe<br \/><a href=\"mailto:meera.lakhani-patel@veeva.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">meera.lakhani-patel@veeva.com<\/a>\u00a0<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1488285\/Veeva_Systems_Logo_v2.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1488285\/Veeva_Systems_Logo_v2.jpg\" title=\"Veeva Systems (PRNewsfoto\/Veeva Systems)\" alt=\"Veeva Systems (PRNewsfoto\/Veeva Systems)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=SF68548&amp;sd=2026-05-27\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/teva-pharmaceuticals-commits-to-veeva-vault-crm-302782645.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/teva-pharmaceuticals-commits-to-veeva-vault-crm-302782645.html<\/a><\/p>\n<p>SOURCE Veeva Systems<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=SF68548&amp;Transmission_Id=202605270703PR_NEWS_USPR_____SF68548&amp;DateId=20260527\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Agentic CRM with industry-specific AI for deeper customer engagement PLEASANTON, Calif., May 27, 2026 \/PRNewswire\/ &#8212; Veeva Systems (NYSE: VEEV) today announced that Teva Pharmaceuticals has committed to Veeva Vault CRM globally. &#8220;We are excited to expand our strategic partnership with Veeva by moving to Vault CRM,&#8221; said Lavanya Narasimhamurthy, global vice president of IT at Teva. &#8220;We share a deep commitment to customer success, and Vault CRM will provide Teva the technical foundation to drive commercial execution.&#8221; &#8220;From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars, and pharmacy brands worldwide, Teva is dedicated to addressing patients&#8217; needs,&#8221; said Veeva President and CCO Tom Schwenger. &#8220;We are honored to extend our strategic &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Teva Pharmaceuticals Commits to Veeva Vault CRM&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-967283","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Teva Pharmaceuticals Commits to Veeva Vault CRM - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Teva Pharmaceuticals Commits to Veeva Vault CRM - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Agentic CRM with industry-specific AI for deeper customer engagement PLEASANTON, Calif., May 27, 2026 \/PRNewswire\/ &#8212; Veeva Systems (NYSE: VEEV) today announced that Teva Pharmaceuticals has committed to Veeva Vault CRM globally. &#8220;We are excited to expand our strategic partnership with Veeva by moving to Vault CRM,&#8221; said Lavanya Narasimhamurthy, global vice president of IT at Teva. &#8220;We share a deep commitment to customer success, and Vault CRM will provide Teva the technical foundation to drive commercial execution.&#8221; &#8220;From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars, and pharmacy brands worldwide, Teva is dedicated to addressing patients&#8217; needs,&#8221; said Veeva President and CCO Tom Schwenger. &#8220;We are honored to extend our strategic &hellip; Continue reading &quot;Teva Pharmaceuticals Commits to Veeva Vault CRM&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-27T11:14:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2988323\/Teva_Pharmaceuticals_Commits_to_Veeva.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-pharmaceuticals-commits-to-veeva-vault-crm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-pharmaceuticals-commits-to-veeva-vault-crm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Teva Pharmaceuticals Commits to Veeva Vault CRM\",\"datePublished\":\"2026-05-27T11:14:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-pharmaceuticals-commits-to-veeva-vault-crm\\\/\"},\"wordCount\":394,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-pharmaceuticals-commits-to-veeva-vault-crm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2988323\\\/Teva_Pharmaceuticals_Commits_to_Veeva.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-pharmaceuticals-commits-to-veeva-vault-crm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-pharmaceuticals-commits-to-veeva-vault-crm\\\/\",\"name\":\"Teva Pharmaceuticals Commits to Veeva Vault CRM - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-pharmaceuticals-commits-to-veeva-vault-crm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-pharmaceuticals-commits-to-veeva-vault-crm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2988323\\\/Teva_Pharmaceuticals_Commits_to_Veeva.jpg\",\"datePublished\":\"2026-05-27T11:14:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-pharmaceuticals-commits-to-veeva-vault-crm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-pharmaceuticals-commits-to-veeva-vault-crm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-pharmaceuticals-commits-to-veeva-vault-crm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2988323\\\/Teva_Pharmaceuticals_Commits_to_Veeva.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2988323\\\/Teva_Pharmaceuticals_Commits_to_Veeva.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teva-pharmaceuticals-commits-to-veeva-vault-crm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Teva Pharmaceuticals Commits to Veeva Vault CRM\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Teva Pharmaceuticals Commits to Veeva Vault CRM - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/","og_locale":"en_US","og_type":"article","og_title":"Teva Pharmaceuticals Commits to Veeva Vault CRM - Market Newsdesk","og_description":"PR Newswire Agentic CRM with industry-specific AI for deeper customer engagement PLEASANTON, Calif., May 27, 2026 \/PRNewswire\/ &#8212; Veeva Systems (NYSE: VEEV) today announced that Teva Pharmaceuticals has committed to Veeva Vault CRM globally. &#8220;We are excited to expand our strategic partnership with Veeva by moving to Vault CRM,&#8221; said Lavanya Narasimhamurthy, global vice president of IT at Teva. &#8220;We share a deep commitment to customer success, and Vault CRM will provide Teva the technical foundation to drive commercial execution.&#8221; &#8220;From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars, and pharmacy brands worldwide, Teva is dedicated to addressing patients&#8217; needs,&#8221; said Veeva President and CCO Tom Schwenger. &#8220;We are honored to extend our strategic &hellip; Continue reading \"Teva Pharmaceuticals Commits to Veeva Vault CRM\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-27T11:14:50+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2988323\/Teva_Pharmaceuticals_Commits_to_Veeva.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Teva Pharmaceuticals Commits to Veeva Vault CRM","datePublished":"2026-05-27T11:14:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/"},"wordCount":394,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2988323\/Teva_Pharmaceuticals_Commits_to_Veeva.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/","name":"Teva Pharmaceuticals Commits to Veeva Vault CRM - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2988323\/Teva_Pharmaceuticals_Commits_to_Veeva.jpg","datePublished":"2026-05-27T11:14:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2988323\/Teva_Pharmaceuticals_Commits_to_Veeva.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2988323\/Teva_Pharmaceuticals_Commits_to_Veeva.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teva-pharmaceuticals-commits-to-veeva-vault-crm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Teva Pharmaceuticals Commits to Veeva Vault CRM"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/967283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=967283"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/967283\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=967283"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=967283"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=967283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}